Compare RACE & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RACE | BDX |
|---|---|---|
| Founded | 1947 | 1897 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.2B | 55.5B |
| IPO Year | 2015 | 1962 |
| Metric | RACE | BDX |
|---|---|---|
| Price | $354.17 | $208.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | ★ $495.00 | $205.25 |
| AVG Volume (30 Days) | 580.9K | ★ 1.7M |
| Earning Date | 02-10-2026 | 02-04-2026 |
| Dividend Yield | 0.97% | ★ 2.02% |
| EPS Growth | ★ 13.13 | N/A |
| EPS | ★ 10.52 | 5.82 |
| Revenue | $8,306,934,179.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $8.84 | $4.01 |
| Revenue Next Year | $5.97 | $3.38 |
| P/E Ratio | ★ $33.84 | $35.64 |
| Revenue Growth | ★ 9.52 | 8.24 |
| 52 Week Low | $350.66 | $162.29 |
| 52 Week High | $519.10 | $251.99 |
| Indicator | RACE | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 35.11 | 67.12 |
| Support Level | $350.66 | $198.44 |
| Resistance Level | $380.42 | $206.99 |
| Average True Range (ATR) | 6.85 | 4.27 |
| MACD | -1.11 | 0.74 |
| Stochastic Oscillator | 13.68 | 96.37 |
Ferrari designs, engineers, and manufactures some of the world's most expensive luxury cars. With supply carefully controlled to be below demand and a brand steeped in decades of motor racing history, a Ferrari is viewed as a status symbol. In 2024, the company sold 13,752 vehicles at an average price over EUR 480,000 with more than 70% of its vehicles being sold to existing Ferrari clients. Eighty-six percent of revenue is generated from the sale of cars and spare parts and 10% from sponsorship, commercial, and brand activities including racing and lifestyle activities. In 2024, the Europe, Middle East, and Africa region accounted for 47% of revenue, the Americas was 33%, mainland China, Hong Kong, and Taiwan was 8%, and the rest of Asia was 12%.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.